Ocular Therapeutix, Inc.
OCUL
$11.37
$0.121.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.06% | 25.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.06% | 25.81% | |||
| Cost of Revenue | 2.09% | 20.19% | |||
| Gross Profit | -0.06% | -18.39% | |||
| SG&A Expenses | 3.69% | -7.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.64% | 8.69% | |||
| Operating Income | -1.56% | -5.83% | |||
| Income Before Tax | -2.37% | -5.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.37% | -5.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.37% | -5.87% | |||
| EBIT | -1.56% | -5.83% | |||
| EBITDA | -1.52% | -5.85% | |||
| EPS Basic | 3.95% | -3.91% | |||
| Normalized Basic EPS | 3.99% | -3.98% | |||
| EPS Diluted | 3.28% | -3.39% | |||
| Normalized Diluted EPS | 3.99% | -3.98% | |||
| Average Basic Shares Outstanding | 6.56% | 1.89% | |||
| Average Diluted Shares Outstanding | 6.56% | 1.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||